Literature DB >> 21353251

Noninvasive assessment of filling pressure and left atrial pressure overload in severe aortic valve stenosis: relation to ventricular remodeling and clinical outcome after aortic valve replacement.

Jordi S Dahl1, Lars Videbæk, Mikael K Poulsen, Patricia A Pellikka, Karsten Veien, Lars Ib Andersen, Torben Haghfelt, Jacob E Møller.   

Abstract

OBJECTIVE: One of the hemodynamic consequences of aortic valve stenosis is pressure overload leading to left atrial dilatation. Left atrial size is a known risk factor providing prognostic information in several cardiac conditions. It is not known if this is also the case in patients with aortic valve stenosis after aortic valve replacement.
METHODS: A total of 119 patients with severe aortic valve stenosis scheduled for aortic valve replacement were evaluated preoperatively and divided into 2 groups according to left atrial volume index (≥40 mL/m(2)). Echocardiography was repeated 12 months after surgery. Patients were followed up for 24 months. The primary end point was the composite end point overall mortality and hospitalization due to congestive heart failure.
RESULTS: Preoperative left atrial dilation was associated with left ventricular hypertrophy and increased filling pressure. Preoperative left atrial volume index was associated with persistent abnormalities in left ventricular filling pressure and left ventricular mass index at 1 year after surgery. Event-free survival in patients with left atrial volume index of 40 mL/m(2) or more at 1 year was 71% compared with 88% in patients with left atrial volume index less than 40 mL/m(2) (P = .002). Patients with preoperative increased E/e' ratio and left ventricular hypertrophy were at increased risk. In Cox regression analysis after correcting for standard risk factors, left atrial volume index was found to be the only significant predictor of the composite end point. In a forward conditional multivariable model, left atrial volume index 40 mL/m(2) or greater (hazard ratio, 4.2 [1.6-10.7]; P = .003) remained an independent predictor, whereas E/e' was borderline significant (P = .06).
CONCLUSIONS: In patients with symptomatic severe aortic valve stenosis undergoing aortic valve replacement, left atrial volume provides important prognostic information beyond standard risk factors.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353251     DOI: 10.1016/j.jtcvs.2011.01.032

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Valve hemodynamic performance and myocardial strain after implantation of a third-generation, balloon-expandable, transcatheter aortic valve.

Authors:  Sara Fernandez-Santos; Alexis Théron; Philippe Pibarot; Frédéric Collart; Martine Gilard; Marina Urena; Tomas Hovorka; Philipp Kahlert; José Luis Zamorano Gomez
Journal:  Cardiol J       Date:  2019-05-20       Impact factor: 2.737

2.  Left atrial remodelling in patients undergoing transcatheter aortic valve implantation: a speckle-tracking prospective, longitudinal study.

Authors:  Flavio D'Ascenzi; Matteo Cameli; Michael Henein; Alessandro Iadanza; Rosanna Reccia; Matteo Lisi; Valeria Curci; Giuseppe Sinicropi; Andrea Torrisi; Carlo Pierli; Sergio Mondillo
Journal:  Int J Cardiovasc Imaging       Date:  2013-07-14       Impact factor: 2.357

3.  Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.

Authors:  Miho Fukui; Aman Gupta; Islam Abdelkarim; Michael S Sharbaugh; Andrew D Althouse; Hesham Elzomor; Suresh Mulukutla; Joon S Lee; John T Schindler; Thomas G Gleason; João L Cavalcante
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

Review 4.  Aortic Stenosis: New Insights in Diagnosis, Treatment, and Prevention.

Authors:  Saki Ito; Jae K Oh
Journal:  Korean Circ J       Date:  2022-10       Impact factor: 3.101

5.  Association of left atrial structure and function and incident cardiovascular disease in patients with diabetes mellitus: results from multi-ethnic study of atherosclerosis (MESA).

Authors:  Timothy M Markman; Mohammadali Habibi; Bharath Ambale Venkatesh; Mytra Zareian; Colin Wu; Susan R Heckbert; David A Bluemke; Joao A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-10-01       Impact factor: 6.875

6.  Effect of transcatheter aortic valve replacement on P-wave duration, P-wave dispersion and left atrial size.

Authors:  Huseyin Dursun; Zulkif Tanriverdi; Tugce Colluoglu; Dayimi Kaya
Journal:  J Geriatr Cardiol       Date:  2015-11       Impact factor: 3.327

7.  Simultaneous Estimation of Gender Male and Atrial Fibrillation as Risk Factors for Adverse Outcomes Following Transcatheter Aortic Valve Implantation.

Authors:  Yuichi Chikata; Hiroshi Iwata; Shinichiro Doi; Takehiro Funamizu; Shinya Okazaki; Shizuyuki Dohi; Ryosuke Higuchi; Mike Saji; Itaru Takamisawa; Harutoshi Tamura; Atsushi Amano; Hiroyuki Daida; Tohru Minamino
Journal:  J Clin Med       Date:  2020-12-07       Impact factor: 4.241

8.  Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.

Authors:  Lisa B VanWagner; Jane E Wilcox; Laura A Colangelo; Donald M Lloyd-Jones; J Jeffrey Carr; Joao A Lima; Cora E Lewis; Mary E Rinella; Sanjiv J Shah
Journal:  Hepatology       Date:  2015-06-26       Impact factor: 17.298

9.  Assessment of left ventricular diastolic function after Transcatheter aortic valve implantation in aortic stenosis patients by echocardiographic according to different guidelines.

Authors:  Yao Guo; Minmin Sun; Haiyan Chen; Dehong Kong; Xianhong Shu; Cuizhen Pan
Journal:  Cardiovasc Ultrasound       Date:  2020-01-21       Impact factor: 2.062

10.  Left atrial and left atrial appendage remodeling after transcatheter aortic valve replacement: Preliminary results.

Authors:  Tian-Yuan Xiong; Fei Chen; Yi-Jian Li; Yuan Feng; Mao Chen
Journal:  Cardiol J       Date:  2021-06-24       Impact factor: 2.737

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.